0
Your cart

Your cart is empty

Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries

Buy Now

Risk-sharing in the Pharmaceutical Industry - The Case of Out-licensing (Paperback, 2006 ed.) Loot Price: R2,975
Discovery Miles 29 750
Risk-sharing in the Pharmaceutical Industry - The Case of Out-licensing (Paperback, 2006 ed.): Gerrit Reepmeyer

Risk-sharing in the Pharmaceutical Industry - The Case of Out-licensing (Paperback, 2006 ed.)

Gerrit Reepmeyer

Series: Contributions to Management Science

 (sign in to rate)
Loot Price R2,975 Discovery Miles 29 750 | Repayment Terms: R279 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The consequences are devastating. Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously. Particularly if a company is highly dependent on just a handful of mega-selling blockbuster drugs, the risks can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical companies have started to organize their R&D in partnership. In fact, more than 600 alliances in pharmaceutical R&D are signed every year."

General

Imprint: Physica-Verlag
Country of origin: Germany
Series: Contributions to Management Science
Release date: December 2005
First published: 2006
Authors: Gerrit Reepmeyer
Dimensions: 235 x 155 x 16mm (L x W x T)
Format: Paperback
Pages: 297
Edition: 2006 ed.
ISBN-13: 978-3-7908-1667-9
Categories: Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
Promotions
LSN: 3-7908-1667-1
Barcode: 9783790816679

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Empire Of Pain - The Secret History of…
Patrick Radden Keefe Paperback R385 R349 Discovery Miles 3 490
Pharmacology In Clinical Practice…
Gustav Schellack Paperback R512 Discovery Miles 5 120
Advanced Nanoformulations - Theranostic…
Md Saquib Hasnain, Amit Kumar Nayak, … Paperback R4,223 Discovery Miles 42 230
Drug Delivery Systems for Metabolic…
Harish Dureja, Narasimha Murthy, … Paperback R4,171 Discovery Miles 41 710
Targeted Nanomedicine for Breast Cancer…
Shivani Rai Paliwal, Rishi Paliwal Paperback R4,773 Discovery Miles 47 730
Tamoxifen Tales - Suggestions for…
V.Craig Jordan Hardcover R2,211 Discovery Miles 22 110
Herbal Bioactive-Based Drug Delivery…
Inderbir Singh Bakshi, Rajni Bala, … Paperback R4,215 Discovery Miles 42 150
Process Systems Engineering for…
Ravendra Singh, Zhihong Yuan Hardcover R5,865 R5,428 Discovery Miles 54 280
Orphan Drugs - Understanding the Rare…
Elizabeth Hernberg-Stahl, Miroslav Reljanović Hardcover R4,474 Discovery Miles 44 740
Patently Innovative - How Pharmaceutical…
R A Bouchard Hardcover R4,301 Discovery Miles 43 010
Pharmacoeconomics
Tom Walley, Alan Haycox, … Paperback R1,299 Discovery Miles 12 990
Technology Transfer, Dependence, and…
Sunil K. Sahu Hardcover R2,979 Discovery Miles 29 790

See more

Partners